The Valley Desk

NCT03251924 · Interventional trial

A Dose Escalation and Combination Immunotherapy Study to Evaluate BMS-986226 Alone or in Combination With Nivolumab or Ipilimumab in Patients With Advanced Solid Tumors

Overall registry status Terminated

Phase 1 · Phase 2

Conditions Cancer, Malignancy, Neoplasm, Tumors

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov